1461098598-cb21a113-83b4-4bb2-8ba8-3b3b84cf5e68

1. An amplifier comprising:
a plurality of amplifier output stages;
a single preamplifier stage configured to separately drive each of said plurality of amplifier output stages; and
a switching means for coupling an output from said preamplifier stage to a selected amplifier output stage, said switching means further couples a feedback loop from said selected amplifier output stage to said preamplifier stage.
2. The amplifier of claim 1 wherein at least one amplifier output stage is configured to drive an audio transducer.
3. The amplifier of claim 1 wherein said selected feedback loop applies a bias voltage to said preamplifier stage.
4. The amplifier of claim 1 wherein said switching means is performed by at least one transistor.
5. The amplifier of claim 1 wherein said switching means couples said feedback loop from said selected amplifier output stages to said preamplifier stage after a predetermined time delay.
6. The amplifier of claim 1 wherein said switching means couples at least one voltage signal to at least one non-selected amplifier output stage to operate said at least one non-selected amplifier output stage in a low power state.
7. The amplifier of claim 1 wherein said switching means decouples said preamplifier stage from all amplifier output stages.
8. An amplifier comprising:
a plurality of amplifier output stages;
a single preamplifier stage configured to drive said plurality of amplifier output stages; and
a plurality of MOS switches configured to couple an output from said preamplifier stage to a selected amplifier output stage, the plurality of switches being further configured to couple a selected feedback loop from said selected amplifier output stage to said preamplifier stage.
9. The amplifier of claim 8 wherein at least one amplifier output stage is configured to drive an audio transducer.
10. The amplifier of claim 8 wherein said selected feedback loop applies a bias voltage to said preamplifier stage.
11. The amplifier of claim 8 wherein at least one of said plurality of MOS switches has an on-resistance that is smaller than an impedance of circuitry in said selected feedback loop.
12. The amplifier of claim 8 wherein said plurality of MOS switches couples said feedback loop from said selected amplifier output stages to said preamplifier stage after a predetermined time delay.
13. The amplifier of claim 8 wherein said plurality of MOS switches couples at least one voltage signal to at least one non-selected amplifier output stage to operate said at least one non-selected amplifier output stage in a low power state.
14. The amplifier of claim 8 wherein said plurality of MOS switches decouples said preamplifier stage from all amplifier output stages.
15. A method for switching an amplifier, the method comprising:
coupling a single pre-amplifier stage to a single selected amplifier output stage from a plurality of amplifier output stages; and
coupling a feedback loop from said selected amplifier output stage to said single preamplifier stage.
16. The method of claim 15 further comprising driving an audio transducer with said selected amplifier output stage.
17. The method of claim 15 further comprising applying a bias voltage to said preamplifier stage.
18. The method of claim 15 wherein said step of coupling a feedback loop is performed after a predetermined time delay following coupling of said single pre-amplifier stage to a single selected amplifier output stage.
19. The method of claim 15 further comprising coupling at least one voltage signal to at least one non-selected amplifier output stage to operate said at least one non-selected amplifier output stage in a low power state.
20. The method of claim 15 further comprising decoupling said preamplifier stage from all amplifier output stages and decoupling said preamplifier stage from all feedback loops.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A minocycline compound selected from the group consisting of:
and a pharmaceutically acceptable salt thereof.
2. A method for treating a bacterial infection in a mammal, comprising administering to said mammal a minocycline compound of claim 1, such that said mammal is treated.
3. The method of claim 2, wherein said bacterial infection is an E. coli infection.
4. The method of claim 2, wherein said bacterial infection is a S. aureus infection.
5. The method of claim 2, wherein said bacterial infection is an E. faecalis infection.
6. The method of claim 2, wherein said bacterial infection is resistant to other tetracycline antibiotics.
7. The method of claim 2, wherein said minocycline compound is administered with a pharmaceutically acceptable carrier.
8. The method of claim 2, wherein said mammal is a human.
9. A pharmaceutical composition comprising a therapeutically effective amount of a minocycline compound of claim 1 and a pharmaceutically acceptable carrier.